CuraSen Therapeutics, Inc.
San Carlos, US · Founded 2016 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
AP
Anthony P. FordExecutive Officer, Director
BP
Benjamin PotterExecutive Officer
HS
Henry SkinnerDirector
LR
Liam RatcliffeDirector
RH
Ron HuntDirector
LT
Loretta Tse, Ph.D.Director
ST
Simon Tate, Ph.D.Director
PE
Patrick EnrightDirector
KS
Kathleen Sereda GlaubDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$5.8MraisedSep 2024 · 7 investors · BiotechnologyRule 506(b)
▶$5.8MraisedSep 2024 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ron HuntDirector
- Anthony P. FordExecutive Officer, Director
- Benjamin PotterExecutive Officer
- Loretta Tse, Ph.D.Director
- Kathleen Sereda GlaubDirector
- Simon Tate, Ph.D.Director
- Patrick EnrightDirector
- Offering amount
- $45.7M
- Amount sold
- $5.8M
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$17.6MraisedOct 2023 · 11 investors · BiotechnologyRule 506(b)
▶$17.6MraisedOct 2023 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anthony P. FordDirector, Executive Officer
- Simon TateDirector
- Patrick EnrightDirector
- Loretta Tse, Ph.D.Director
- Benjamin PotterExecutive Officer
- Kathleen Sereda GlaubDirector
- Ron HuntDirector
- Offering amount
- $20.8M
- Amount sold
- $17.6M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$18MraisedNov 2021 · 10 investors · BiotechnologyRule 506(b)
▶$18MraisedNov 2021 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Patrick EnrightDirector
- Benjamin PotterExecutive Officer
- Anthony P FordDirector, Executive Officer
- Ron HuntDirector
- Loretta Tse, Ph.D.Director
- Simon TateDirector
- Kathleen Sereda GlaubDirector
- Offering amount
- $18M
- Amount sold
- $18M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$27.2MraisedJan 2019 · 10 investors · BiotechnologyRule 506(c)
▶$27.2MraisedJan 2019 · 10 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Henry SkinnerDirector
- Patrick EnrightDirector
- Liam RatcliffeDirector
- Benjamin PotterExecutive Officer
- Anthony P. FordExecutive Officer, Director
- Kathleen Sereda GlaubDirector
- Offering amount
- $54.5M
- Amount sold
- $27.2M
- Minimum investment
- $1
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.